dextranomer

for treatment of burns; consists of three-dimensional network of dextran polymers cross-linked by epichlorohydrin; dextranomer based implants usedas a bulking agent for endoscopic treatment of pediatric structural incontinence; ingredient of dextranomer-hyaluronic acid copolymer which is used to treat primary vesicoureteral reflux;

Also Known As:

Networked: 250 relevant articles (41 outcomes, 33 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Kirsch, Andrew J: 15 articles (11/2021 - 07/2003)
2.	Scherz, Hal C: 10 articles (08/2012 - 07/2003)
3.	Reinberg, Yuri: 6 articles (05/2010 - 10/2006)
4.	Routh, Jonathan C: 6 articles (05/2010 - 10/2006)
5.	Läckgren, Göran: 5 articles (11/2021 - 10/2003)
6.	Puri, Prem: 5 articles (01/2018 - 10/2006)
7.	Koyle, Martin A: 5 articles (05/2010 - 10/2004)
8.	Vandersteen, David R: 5 articles (08/2008 - 10/2006)
9.	Stenberg, Arne: 4 articles (01/2020 - 10/2003)
10.	Colhoun, Eric: 4 articles (01/2018 - 10/2006)

Related Diseases

1.	Vesico-Ureteral Reflux (Vesicoureteral Reflux) 04/01/2015 - "Factors affecting the success of endoscopic treatment of vesicoureteral reflux and comparison of two dextranomer based bulking agents: does bulking substance matter?" 02/01/2007 - "We performed a multi-institutional study of 80 patients (97 ureters) who were diagnosed with vesicoureteral reflux and had failed endoscopic treatment with dextranomer microspheres. " 09/01/2012 - "The diameter of dextranomer microsphere does not affect the short-term success rate in endoscopic treatment of vesicoureteral reflux. " 09/01/2012 - "Does the diameter of dextranomer microspheres affect the success in endoscopic treatment of vesicoureteral reflux?" 02/01/2007 - "A review of failures of endoscopic treatment of vesicoureteral reflux with dextranomer microspheres."
2.	Wounds and Injuries (Trauma) 01/01/1976 - "Treatment with Debrisan was found to be very effective in cleansing discharging wounds. " 01/01/1985 - "These results suggest that Debrisan is more effective than gauze for absorbing wound exudate, when applied on an openly secreting wound. " 07/01/1981 - "The quantitative study of the use of dextranomer in the management of infected wounds." 01/01/1976 - "Studies on healing of Debrisan-treated wounds." 01/01/1999 - "To start treatment the wound was dressed with Debrisan crystals and sterile gauze for 1 week. "
3.	Ulcer 11/01/1988 - "[Use of Acudex Polfa in the treatment of chronic crural ulcers]." 05/17/1980 - "The average healing time for ulcers treated with Debrisan and left to heal spontaneously was 4,4 weeks compared with 5,32 weeks for the controls. " 05/17/1980 - "The mean cleansing time for the Debrisan-treated ulcers was 5,9 days, compared with 15,4 days for the control group receiving standard treatment. " 04/19/1980 - "Debrisan effectively desloughs moist exudative ulcers, and allows early skin grafting." 09/01/1978 - "The good results in the use of dextranomer for highly exudative ulcers have also been presented as another adjunct in the local care of venous ulcers."
4.	Pressure Ulcer (Bedsore) 06/13/1981 - "The treatment of decubitus ulcers with dextranomer." 01/01/1981 - "The decubitus ulcers of 4 patients being treated with dextranomer for up to three months were examined. " 01/01/1981 - "The use of dextranomer in decubitus ulcers: a histopathologic evaluation." 04/01/1979 - "Debrisan for decubitus ulcers." 01/01/1979 - "An evaluation of Debrisan in chronic leg ulcers and pressure sores."
5.	Fecal Incontinence 11/01/2014 - "This article reviews both sacral nerve stimulation and dextranomer bulking agents and compares their strengths and potential limitations in patients with fecal incontinence. " 01/01/2023 - "Nonanimal stabilized hyaluronic acid/dextranomer demonstrated clinically significant, sustained improvement in symptoms and quality of life for fecal incontinence patients without the occurrence of any serious adverse events. " 06/01/2009 - "Submucosal injection of stabilized nonanimal hyaluronic acid with dextranomer: a new treatment option for fecal incontinence." 01/01/2023 - "Efficacy and Safety of a Nonanimal Stabilized Hyaluronic Acid/Dextranomer in Improving Fecal Incontinence: A Prospective, Single-Arm, Multicenter, Clinical Study With 36-Month Follow-up." 01/01/2018 - "Dextranomer/hyaluronic acid for the treatment of fecal incontinence has become more common in recent years. "

Related Drugs and Biologics

1.	Hyaluronic Acid (Hyaluronan)
2.	dextranomer
3.	Ointments (Pastes)
4.	Alginates
5.	Hydrogels
6.	Polymers
7.	polyacrylate polyalcohol copolymer
8.	deflux
9.	Eusol
10.	Dextrans (Dextran)

Related Therapies and Procedures

1.	Debridement
2.	Injections
3.	Antibiotic Prophylaxis
4.	Therapeutics
5.	Replantation